Preparation of nosiheptide liposomes and its inhibitory effect on hepatitics B virus in vitro

Yaoxue Xuebao

Volumn 40, Issue 5, 2005, Pages 462-465

  Cai, Qin Sheng ^a   Huang, Hai ^a   Feng, Mei Qing ^a   Zhou, Pei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Anti HBV; Encapsulation efficiency; Liposomes; Nosiheptide; Particle size

Indexed keywords

ANTIVIRUS AGENT; DRUG CARRIER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LIPOSOME; NOSIHEPTIDE; THIAZOLE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG STABILITY; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; IMMUNOLOGY; LIVER TUMOR; PARTICLE SIZE; TUMOR CELL LINE; VIROLOGY;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMANS; LIPOSOMES; LIVER NEOPLASMS; PARTICLE SIZE; THIAZOLES;

EID: 22244461144     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Li Y, Dosch DC, Strohl WR, et al. Nucleotide sequence and transcriptional analysis of the nosiheptide-resistance gene from Streptomyces actuosus. Gene, 1990,91 (1):9-17.
2. Zhou P. Biosynthesis of Nosiheptide and Pyridinyl Polythiazole Class Peptide Antibiotic [D]. Shanghai: Shanghai Medcial University, 1993. 1-25.
3. Wu T, Huang H, Zhou P. The inhibitory of nosiheptide on Hepatitis B Virus in vitro. Chin J Antibiot, 1997,22(5):373-376.
4. Zhou P. Biosynthesis of nosiheptide. Chin J Antibiot, 1995,6(5):16-17.
5. Cai QS. Preparation and Liver Targeting of rHDL-Anti HBV Drug Complexes [D]. Shanghai: Fudan University, 2004. 40-48.
6. Horii S, Oku N. Rapid determination of nosiheptide in meat and egg by liquid chromatography with fluorescence detection. J AOAC Int, 2000,83(1):17-19.